Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report.

Shinya OtaniRobert T NakayamaTetsuya SekitaToru HirozaneNaofumi AsanoKazumasa NishimotoAya SasakiHajime OkitaHideo MoriokaMasaya NakamuraMorio Matsumoto

Published in: BMC cancer (2019)

Denosumab plays a certain role in prevention of bone destruction by PMHE through suppression of osteoclast-like giant cells and would be an excellent treatment for bone absorption by PMHE of bone.

Keyphrases

bone mineral density
postmenopausal women
bone loss
soft tissue
body composition
bone regeneration
cell proliferation
cell cycle arrest
cell death
smoking cessation